Medicine guide

LIVTENCITY

As listed in the register: LIVTENCITY 200 mg, comprimé pelliculé

200 mg · comprimé pelliculé

  • Prescription only
Active substance
Maribavir
Made by
TAKEDA PHARMACEUTICALS INTERNATIONAL (IRLANDE)

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

European UnionNo exact match for this strength and form

Details

Made byTAKEDA PHARMACEUTICALS INTERNATIONAL (IRLANDE)
Active substanceMaribavir
Strength200 mg
Formcomprimé pelliculé
Routeorale
Dispensing (as stated by the register)prescription hospitalière · liste I
MarketedYes, according to the register
Reinforced monitoringYes — under reinforced monitoring, according to the register
Authorisation procedureProcédure centralisée
EU numberEU/1/22/1672
Name in the registerLIVTENCITY 200 mg, comprimé pelliculé
Packsflacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 28 comprimé(s)
CIS66919901
CIP133400930262498

Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician

Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).